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Abstract
The palladium-catalyzed nucleophilic substitution of (coumarinyl)methyl acetates is described. The reaction proceeds though a
palladium π-benzyl-like complex and allows for many different types of C-, N-, and S-nucleophiles to be regioselectively added to
the biologically active coumarin motif. This new method was utilized to prepare a 128-membered library of aminated coumarins for
biological screening.
Introduction
Coumarins are privileged chemical motifs found in many
natural products and drug molecules [1-15]. Because of their
biological significance, there have been many classic and
modern methods developed for the synthesis of these useful
core structures [16-24]. Due to the ambiphilic nature of the
heterocyclic ring of coumarin, this core-structure undergoes a
diverse array of coupling reactions, such as halogenations [25],
cycloadditions [26-32], conjugate additions [33-37] and tran-
sition-metal-catalyzed C–H activation/coupling reactions
[38-44].
Substituted methylcoumarins, including aminomethyl-
coumarins are important biologically active motifs (Figure 1)
[6-15]. Substitution of methylcoumarins to form compounds
akin to 2 typically utilizes the corresponding halomethyl-
coumarin and highly stabilized nucleophiles or amines [6-15].
Due to the sensitivity and toxicity of related benzyl halides,
there has been interest in catalytically activating hydroxy-
methylarene and heteroarenes (e.g., benzyl alcohol derivatives)
toward reactions with nucleophiles [45-55]. In this realm, we
[53,55] and others [54] have focused efforts on catalyzing
Beilstein J. Org. Chem. 2012, 8, 1200–1207.
1201
Figure 1: Representative biologically active aminomethylcoumarins.
benzylic substitutions with less-stabilized (DMSO pKa ~ 20–30)
nucleophiles through decarboxylative coupling. In the present
context, we hypothesized that a broad diversity of nucleophiles
could be added to the (coumarinyl)methyl core through palla-
dium-catalyzed couplings of hydroxymethylcoumarin deriva-
tives. Herein we report that hydroxymethylcoumarin deriva-
tives of type-1 undergo selective nucleophilic substitution at the
exo-methyl position with C-, N-, and S-based nucleophiles by
using palladium(0) as a catalyst (Scheme 1). In addition, given
the known biological activity of aminomethylcoumarins, we
prepared a 128-member library of aminated coumarins using
rapid automated synthesis.
Scheme 1: Approach to diversely substituted coumarins.
Results and Discussion
To begin investigating the diversification of hydroxymethyl-
coumarins, we chose to investigate their decarboxylative
couplings of enolates. We have previously shown that decar-
boxylative benzylation (DcB) is a useful method for the addi-
tion of less-stabilized enolate anions to a benzyl functionality
[46,53-55]. Thus, we envisioned being able to add various
ketone enolates to the exo-methyl position of the coumarin core
by this method (Table 1). Screening of reaction conditions
showed that, in contrast to common decarboxylative benzyla-
tion conditions (Table 1,entries 1 and 2) under which nonpolar
solvents give the best DcB, the selective mono-alkylation of the
enolate proceeds in highest yield in acetonitrile (2a, Table 1,
entry 3). Bidentate ligated palladium complexes gave mixed
results: the Pd/dppf complex (Table 1,entry 4) catalyzed the
reaction smoothly, while little product was seen on using the
Pd/BINAP complex (Table 1,entry 5). Under the best condi-
Table 1: Reaction development for the coupling of in situ generated
enolates and coumarin π-benzyl complexes.
Entry Catalyst Solvent Conv. (%)
1 Pd(PPh3)4 toluene 68
2 Pd(PPh3)4 THF 70
3 Pd(PPh3)4 MeCN 95 (88% yield)
4 Pd2dba3, dppf MeCN 88
5 Pd2dba3, BINAP MeCN 10
Scheme 2: Scope of the decarboxylative coupling.
tions (5 mol % Pd(PPh3)4, MeCN, rt, Table 1, entry 3), a variety
of enolate nucleophiles could be selectively coupled with
coumarin electrophiles (Scheme 2). For example, acetone,
acetophenone and 1,1,1-trimethylacetone enolates can all be
generated and coupled with the coumarin electrophile. Impor-
tantly, selective monobenzylation was achieved for each
example. Regarding the coumarin moiety, the decarboxylative
coupling was compatible with a variety of simple substitutions,
including methoxy (2c,d,g,h), chloro (2g,h) and naphthyl (2e)
coumarins.
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Scheme 3: Scope of Suzuki-coupling of coumarinyl acetates.
While the decarboxylative coupling worked well for the
couplings of relatively nonstabilized enolate nucleophiles, we
wished to find a more universal starting material that would
allow a broader range of nucleophiles to be coupled to the
coumarin core in an intermolecular fashion. Such a method was
deemed necessary for rapid diversification and chemical library
synthesis. Thus, we chose to investigate the Pd-catalyzed
benzylic substitution reaction of (coumarinyl)methyl acetates
with various nucleophiles. In the forthcoming sections, the
coupling of this coumarin template to arylboronic acids [56-61],
amines [47] and arylsulfinates is described [62]. Moreover,
compared to related methods for palladium-catalyzed benzylic
substitution that require specialized ligands [45,47,60-62], we
report that coumarin π-benzyl formation is easily achieved with
simple PPh3 ligated palladium.
Regarding the development of the Suzuki-like coupling reac-
tion of (coumarinyl)methyl acetate and arylboronic acids, we
screened reaction conditions for the coupling of coumarin 1a
with phenylboronic acid (Table 2). We were pleased to find that
the reaction progressed reasonably well to 3a under various
conditions. For example, inorganic bases such as K2CO3,
K3PO4, and KF all effected the reaction equally well in
methanol. A brief screen of solvents showed that the nonpolar
aprotic solvent 1,4-dioxane gave the highest yields of the
coupling product (Table 2, entry 6). Lastly, in the absence of
added base, the acetate generated upon π-benzyl formation also
promoted the desired coupling, albeit in lower yield over the
time frame allowed (12 h, Table 2, entry 7).
Table 2: Palladium-catalyzed coupling of coumarinyl acetate and
phenylboronic acid.
Entry Solvent T (°C) Base Conv. (%)
1 MeOH 65 K2CO3 65
2 MeOH 65 KF 59
3 MeOH 65 K3PO4 65
4 toluene 90 K2CO3 63
5 THF 65 K2CO3 63
6 dioxane 90 K2CO3 85
7 dioxane 90 – 45
With the optimal conditions in hand, we next tested the scope of
the reaction using various boronic acid and coumarinyl acetates
(Scheme 3). Regarding the boronic acid coupling partner, modi-
fications including fluoro and alkyl substitution were tolerated.
In addition to aryl boronic acids (3a–c), the reaction was also
extended to couplings of vinyl boronic acids having varied elec-
tronic properties (3d–e). As before, various simple substitu-
tions and electronic changes were tolerated on the coumarin
core.
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Scheme 6: Scope of the coumarinyl acetate and amine coupling reaction.
Scheme 4: Coupling of (coumarinyl)methyl acetates with N- and
S-nucleophiles.
In addition to the above Suzuki couplings, acetoxymethyl-
coumarins were found to undergo palladium-catalyzed substitu-
tion with sulfinates and secondary amines under the previously
developed palladium-catalysis conditions (Scheme 4). Impor-
tantly, related aminomethylcoumarins have been shown to have
significant biological activity [6-15].
Regarding the coupling reaction between aryl sulfinates and the
coumarinyl acetate, the reaction could be performed without the
addition of an external base, since the aryl sulfinate is adminis-
tered as its anion (Scheme 5). Phenyl (4a–c) and tolyl (4d–e)
sulfinates were viable coupling partners, giving the product
sulfones in good yield. As previously noted, the coumarin core
Scheme 5: Scope of the coumarinyl acetate and aryl sulfinate coupling
reaction.
tolerated various simple electronic (4b,c,e) and alkyl (4a,c,d)
substitution patterns.
Since (coumarinyl)methylamines are known to possess interest-
ing biological activity, the scope of the amination was investi-
gated in somewhat more detail. Regarding the scope of the
amine and coumarinyl acetate coupling reaction, dialkyl (5a–c)
and the cyclic amines pyrrolidine (5d–5f), pyrazine (5g), and
morpholine (5h) were competent coupling partners (Scheme 6).
Primary amines were also compatible coupling partners,
although under these conditions, the reaction never went to full
conversion (5i–k).
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As mentioned previously, we were devising this approach to
coumarin substitution not only for the sake of new chemical
methodology, but also because this approach could easily lead
to rapid library synthesis. As aminomethylcoumarins are a bio-
logically active chemical motif [6-15], we set out to produce a
128-member library of aminated coumarins using our method,
with the goal of making unique, biologically active molecules
(Figure 2). To begin, an 8 × 16 library (coumarin C1–8 × amine
A1–16) of aminomethylcoumarins was devised for preparation
by using a Chemspeed SLT100 automated synthesizer. For
automated synthesis, the procedure and workflow was modi-
fied somewhat for optimal yield. Specifically, the loading of Pd
was lowered to 3 mol % and the quantity of amine was raised to
1.5 equivalents to ensure complete conversion. Using the work-
flow shown in Figure 2 for the reaction of coumarin C3 with
diallylamine A4, followed by filtration through a silica SPE,
produced product C3A4 in 74% yield in a test case. In addition,
the product was determined to contain 2% PPh3 impurity. Thus,
it was concluded that the entire library should be purified by
mass-directed fractionation to ensure high-quality compounds
for biological screening.
Regarding the library, coumarins and amines were chosen with
diverse structures and properties in order to access the most
chemical space within the aminomethylcoumarin family
(Figure 2). The coumarins utilized had various electronic prop-
erties and substitution patterns. A polyaromatic coumarin was
also screened (C4). Similarly, a diverse array of amines was
chosen. Aside from simple dialkylamines, cyclic and
heteroatom-containing amines were utilized. Amines with
various functional groups, such as amides, aromatics, olefins,
and alkyne substitution patterns, were also incorporated in this
library. The automated library synthesis had a success rate of
>85%, with the desired products isolated in high purity [63].
Taking center cuts by using mass-directed fractionation ensured
that compounds were isolated in >95% purity; however, purity
was achieved at some expense to the isolated yields, which
were typically lower (5–75%) than those achieved in batch
reactions. While most compounds were obtained in sufficient
quantity for biological screening, the yields were variable
(Figure 3). In particular, coumarins C6, C2 and C8 provided
lower average yields than the other coumarin cores. Thus, it
appears that 6,7-substitution of the coumarin core is somewhat
problematic. In addition, analysis of the library yields indicates
that N-arylpiperazines A8 and A9 in addition to propargyl-
amine A15 were the most problematic. Perhaps unsurprisingly,
the amine that provided the highest yields and highest success
rate was diallyl amine, which was used for initial validation of
the Chemspeed method (see above). In addition, piperidine and
the simple open-chain dialkyl amines also provided good yields
and high success rates.
Figure 2: Library planning for amine (A) and coumarin (C) coupling
partners.
Conclusion
In conclusion, we have developed a simple and general strategy
for the palladium-catalyzed substitution of coumarins selec-
tively at an exomethyl position. This approach allowed the
coupling of various C-,N-, and S-based nucleophiles under mild
conditions. We also utilized this approach in the synthesis of a
128-member chemical library appropriate for biological
screening.
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Figure 3: Results for the synthesis of a 128-member library of aminated coumarins by using the Chemspeed SLT100 automated synthesizer. Puri-
fied by an automated preparative reverse-phase HPLC (Waters 2767 Mass Directed Fractionation) detected by UV (270 nm). Purity was determined
by reverse-phase HPLC (Waters Alliance 2795 system) with peak area (UV) at 214 nm.
Supporting Information
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new compounds produced in batch.
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